US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 1.4700
  • +0.0700+5.00%
Close Nov 22 16:00 ET
  • 1.5100
  • +0.0400+2.72%
Post 20:02 ET
96.29MMarket Cap-1441P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
87.20%15.21M
67.60%12.26M
19.77%8.83M
10.16%31.11M
19.73%8.3M
7.43%8.13M
1.95%7.32M
12.18%7.37M
1.52%28.24M
-0.40%6.93M
Selling and administrative expenses
46.49%3.86M
68.92%3.95M
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
-General and administrative expense
46.49%3.86M
68.92%3.95M
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
Research and development costs
106.76%11.35M
66.98%8.31M
22.64%6.04M
14.89%21.15M
22.28%5.76M
3.35%5.49M
5.69%4.98M
33.87%4.93M
3.46%18.41M
6.89%4.71M
Operating profit
-87.20%-15.21M
-67.60%-12.26M
-19.77%-8.83M
-10.16%-31.11M
-19.73%-8.3M
-7.43%-8.13M
-1.95%-7.32M
-12.18%-7.37M
-1.52%-28.24M
0.40%-6.93M
Net non-operating interest income expense
281.40%1.15M
304.29%1.23M
55.22%357K
1,392.77%1.07M
74.45%239K
2,408.33%301K
465.06%303K
254.36%230K
-1,022.22%-83K
179.19%137K
Non-operating interest income
163.24%1.15M
172.40%1.28M
5.54%438K
177.19%1.68M
6.01%353K
134.22%438K
496.20%471K
6,816.67%415K
-29.98%605K
712.20%333K
Non-operating interest expense
-96.35%5K
-65.48%58K
-56.22%81K
-12.21%604K
-41.84%114K
-21.71%137K
3.70%168K
19.35%185K
-19.53%688K
-8.41%196K
Other net income (expense)
Income before tax
-79.73%-14.06M
-57.37%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.39%-7.01M
-6.27%-7.14M
-1.85%-28.32M
4.74%-6.8M
Income tax
0
0.00%1K
0.00%1K
0
0
1K
0.00%1K
0
Net income
-79.73%-14.06M
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
Net income continuous Operations
-79.73%-14.06M
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
Minority interest income
Net income attributable to the parent company
-79.73%-14.06M
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-79.73%-14.06M
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
Basic earnings per share
47.50%-0.21
54.05%-0.17
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
Diluted earnings per share
47.50%-0.21
54.05%-0.17
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 87.20%15.21M67.60%12.26M19.77%8.83M10.16%31.11M19.73%8.3M7.43%8.13M1.95%7.32M12.18%7.37M1.52%28.24M-0.40%6.93M
Selling and administrative expenses 46.49%3.86M68.92%3.95M13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M
-General and administrative expense 46.49%3.86M68.92%3.95M13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M
Research and development costs 106.76%11.35M66.98%8.31M22.64%6.04M14.89%21.15M22.28%5.76M3.35%5.49M5.69%4.98M33.87%4.93M3.46%18.41M6.89%4.71M
Operating profit -87.20%-15.21M-67.60%-12.26M-19.77%-8.83M-10.16%-31.11M-19.73%-8.3M-7.43%-8.13M-1.95%-7.32M-12.18%-7.37M-1.52%-28.24M0.40%-6.93M
Net non-operating interest income expense 281.40%1.15M304.29%1.23M55.22%357K1,392.77%1.07M74.45%239K2,408.33%301K465.06%303K254.36%230K-1,022.22%-83K179.19%137K
Non-operating interest income 163.24%1.15M172.40%1.28M5.54%438K177.19%1.68M6.01%353K134.22%438K496.20%471K6,816.67%415K-29.98%605K712.20%333K
Non-operating interest expense -96.35%5K-65.48%58K-56.22%81K-12.21%604K-41.84%114K-21.71%137K3.70%168K19.35%185K-19.53%688K-8.41%196K
Other net income (expense)
Income before tax -79.73%-14.06M-57.37%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.39%-7.01M-6.27%-7.14M-1.85%-28.32M4.74%-6.8M
Income tax 00.00%1K0.00%1K001K0.00%1K0
Net income -79.73%-14.06M-57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M
Net income continuous Operations -79.73%-14.06M-57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M
Minority interest income
Net income attributable to the parent company -79.73%-14.06M-57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -79.73%-14.06M-57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M
Basic earnings per share 47.50%-0.2154.05%-0.1730.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.4
Diluted earnings per share 47.50%-0.2154.05%-0.1730.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data